MeiraGTx (MGTX) Competitors

Apogee Therapeutics (NASDAQ:APGE) and MeiraGTx (NASDAQ:MGTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability, community ranking and analyst recommendations.

Is APGE or MGTX more profitable?

Apogee Therapeutics has a net margin of 0.00% compared to MeiraGTx's net margin of -633.05%. Apogee Therapeutics' return on equity of -21.81% beat MeiraGTx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apogee Therapeutics	N/A	-21.81%	-20.94%
MeiraGTx	-633.05%	-146.38%	-53.05%

Do analysts prefer APGE or MGTX?

Apogee Therapeutics presently has a consensus target price of $94.60, suggesting a potential upside of 135.44%. MeiraGTx has a consensus target price of $24.00, suggesting a potential upside of 352.83%. Given MeiraGTx's higher probable upside, analysts clearly believe MeiraGTx is more favorable than Apogee Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apogee Therapeutics	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
MeiraGTx	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor APGE or MGTX?

In the previous week, Apogee Therapeutics had 4 more articles in the media than MeiraGTx. MarketBeat recorded 13 mentions for Apogee Therapeutics and 9 mentions for MeiraGTx. Apogee Therapeutics' average media sentiment score of 1.33 beat MeiraGTx's score of 0.06 indicating that Apogee Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apogee Therapeutics	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MeiraGTx	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, APGE or MGTX?

Apogee Therapeutics has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.

Does the MarketBeat Community prefer APGE or MGTX?

MeiraGTx received 166 more outperform votes than Apogee Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Apogee Therapeutics an outperform vote while only 71.85% of users gave MeiraGTx an outperform vote.

Company	Underperform	Outperform
Apogee Therapeutics	Outperform Votes 28 100.00%	Underperform Votes No Votes
MeiraGTx	Outperform Votes 194 71.85%	Underperform Votes 76 28.15%

Do institutionals & insiders have more ownership in APGE or MGTX?

79.0% of Apogee Therapeutics shares are held by institutional investors. Comparatively, 67.5% of MeiraGTx shares are held by institutional investors. 42.8% of Apogee Therapeutics shares are held by insiders. Comparatively, 7.5% of MeiraGTx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has stronger valuation and earnings, APGE or MGTX?

Apogee Therapeutics has higher earnings, but lower revenue than MeiraGTx. Apogee Therapeutics is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apogee Therapeutics	N/A	N/A	-$83.99M	-$3.60	-11.16
MeiraGTx	$34.51M	12.34	-$84.03M	-$2.32	-2.28

Summary

Apogee Therapeutics beats MeiraGTx on 11 of the 16 factors compared between the two stocks.